Predictive Value of Peripheral Blood Biomarkers in the Treatment of 
Lung Cancer Patients with Anti PD-1 Immunotherapy

Conclusion Peripheral blood serum IFN-γ, TNF-α and IL-5 in lung cancer patients have cert ain roles in predicting the clinical efficacy of anti-PD-1 therapy. The decrease in absolute peripheral blood lymphocyte count in lung cancer patients is related to disease progression, but large-scale prospective studies are needed to further elucidate the value of these biomarkers.
 DOI: 10.3779 /j.issn.1009-3419.2023.102.38
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research